Sundia Meditech’s CEO On Driving Innovation In China’s Pharma Sector
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's ballooning middle class, born of market reforms, the extension of health insurance to a widening sector of the populace, and the return of Chinese scientists educated in the West are all driving the rapid-fire expansion of the country's pharmaceutical sector, according to the CEO of Sundia Meditech